Last SFr.258.80 CHF
Change Today -0.20 / -0.08%
Volume 1.7M
ROG On Other Exchanges
Symbol
Exchange
OTC US
OTC US
OTC US
Xetra
SIX Swiss Ex
Xetra
SIX Swiss Ex
Mexico
Frankfurt
As of 11:43 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Severin Schwan Ph.D.

Chief Executive Officer and Director, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 49 board members in 5 different organizations across 12 different industries.

See Board Relationships
47SFr.11,949,634
As of Fiscal Year 2014

Background*

Dr. Severin Schwan, Ph.D. serves as the Chief Executive Officer of F. Hoffmann-La Roche Ltd. Dr. Schwan serves as the Chief Executive Officer of Roche Diabetes Care AG. He has been the Group Chief Executive Officer of Roche Holding AG since March 2008. He serves as the Chief Executive Officer of Roche Group and Roche Holding Ltd. Dr. Schwan served as the Chief Executive Officer of Roche Diagnostics Corporation since January 1, 2006 and its Group Chief Executive Officer ...

Read Full Background

Corporate Headquarters*

Konzern-Hauptsitz
Basel, Basel-Stadt 4070

Switzerland

Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships*

Director and Member of Scientific Resource Board
Former Director
2008-Present
Chairman of the Board
2013-Present
Chief Executive Officer and Director
2014-Present
Director and Member of Risk Committee
2014-Present
Director

Education*

Unknown/Other Education
University of Oxford
Unknown/Other Education 1991
Universität Innsbruck
LLB 1991
Universität Innsbruck
Unknown/Other Education
University of York
Doctorate 1993
Universite catholique de Louvain

Other Affiliations*

Annual Compensation*

SalarySFr.4,000,000
BonusSFr.1,340,136
Total Annual CompensationSFr.5,340,136

Stock Options*

Restricted Stock AwardsSFr.6,056,252
All Other CompensationSFr.553,246
Total Value of OptionsSFr.22,155,938
Total Number of Options289,794

Total Compensation*

Total Annual Cash CompensationSFr.5,893,382
Total Short Term CompensationSFr.5,340,136
Other Long Term CompensationSFr.6,609,498
Total Calculated CompensationSFr.11,949,634
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.258.80 CHF -0.20

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€3.2M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Sanofi
€700.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.